Hip Prosthesis Infection
14
3
4
5
Key Insights
Highlights
Success Rate
83% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
7.1%
1 terminated out of 14 trials
83.3%
-3.2% vs benchmark
7%
1 trials in Phase 3/4
0%
0 of 5 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 5 completed trials
Clinical Trials (14)
Single-stage Surgery With Antibiotic-loaded Hydrogel Coated Implants Versus Two Stage Surgery for Secondary Prevention of Complex Chronic Periprosthetic Hip Joint Infection
Long Term Follow-up of Patients With Prosthetic Joint Infection of the Hip Treated at University Hospitals Leuven
Innovative Technologies for Salvage Procedures of Failed Treatments of Osteoarthritis: Biomimetics Solutions (CustomPN)
Clinical Evaluation and Cost-effectiveness Analysis of 3D Digital Surgery in Traumatology
Early Discrimination of Periprosthetic Hip Infections Using Neural Networks (SEPTIC-ANNR)
Proof of Concept Study to Assess Safety and Efficacy of Phage Therapy in Hip or Knee Prosthetic Joint Infections Due to Staphylococcus Aureus Treated by DAIR.
Contribution of a Clinical Pathway for the Treatment of Hip Prosthesis Infections
Image Quality of EOSedge for Radiographic Evaluation of Hip Implant
Does the Type of Ventilation Affect the Risk for Infections After Hip Replacements?
Susceptibility Testing of Biofilm to Guide Treatment of Periprosthetic Joint Infections
Effect of Sonication on Periprosthetic Joint Infection Treatment Strategy.
DAIR for Infected Total Hip Arthroplasty - Does the Operative Approach Influence the Functional Result?
Prosthetic Hip Infections: Prospective Study
CERAMENTTM|G and V in the Management of Hip and Knee Arthroplasty Revisions (Revision Arthroplasty Italy)